Nanion Upcoming Events

You are viewing the list of upcoming events.
Switch to past events instead.

18.02.2022 | 2022 Satellite Meeting: Drug Discovery for Ion Channels XXII

211123 Event image 2022 Satellite Meeting
Conference Venue
: Esplanade, Room 153, Moscone Center, San Francisco, California, USA

Go to the Conference website here

Nanion is a proud sponsor of next year's Satellite Meeting of the BPS

Registration site is available here


8:00 - 8:30 AM
Registration and Coffee 

8:30 - 8:45 AM
Niels Fertig, Nanion Technologies, Germany
Welcome and Opening Remarks

Session I Chair: Daniel Sauter, Sophion Bioscience, Denmark

08:45 - 09:30 AM
Keynote Speaker: Henry Colecraft, Columbia University, USA

Title: "Regulating Ion Channel Functional Expression and Gating with Engineered Nanobodies"

09:30 - 10:00 AM
Robert Kirby, Metrion Biosciences, United Kingdom

Title: "Development of a Current-Clamp Assay as a Physiologically Relevant Screen for Kv1.3"

10:00 - 10:30 AM
Fitzwilliam Seibertz, University of Göttingen, Germany

Title: "High Performance Characterization of Atrial Cardiomyocytes"

10:30 - 11:00 AM
Coffee Break

Session II Chair: Ali Yehia, Fluxion Biosciences, USA

11:00 - 11:30 AM
Mohammad-Reza Ghovanloo, Yale University, USA

Title: "Inhibition of Sodium Conductance by Cannabigerol Contributes to a Reduction of Neuronal Dorsal Root Ganglion Excitability"

11:30 - 12:00 PM
Ciria Hernandez, University of Michigan, USA

Title: "High-throughput Functional Evaluation of Melanocortin Compounds in the MC4R-Kir7.1 Complex: Biased Signaling at the Melanocortin Receptor 4"

12:00 - 12:30 PM
Eric Wang, University of Florida, USA

Title: "Cell Lines to Facilitate Studies of GABA Receptor Subunit Combinations"

12:30 - 1:30 PM

Session III Chair: Niels Fertig, Nanion Technologies, Germany

1:30 - 2:00 PM
Arpad Mike, Eötvös Loránd University, Hungary

Title: "An Investigation of Sodium Channel Blocker Distribution Dynamics Using the Ionflux Mercury: Why Onset is Not Association, Offset is Not Dissociation, and Block is Not Really Block?"

2:00 - 2:30 PM
Sam Goodchild, Xenon Pharmaceuticals, Canada

Title: "NaV1.1 Selective Potentiators Normalize Inhibition/Excitation Imbalance and Prevent Seizures in a Mouse Model of Dravet Syndrome"

2:30 - 3:00 PM
David Dalrymple, SB Drug Discovery, United Kingdom

Title: "Development of a Screening Cascade for Identification of TMEM175 Modulators"

3:00 - 3:30 PM
Coffee Break

Session IV Chair: Robert Kirby, Metrion Biosciences, United Kingdom

3:30 - 3:55 PM
Kris Kahlig, Praxis Precision Medicines, USA

Title to Come

3:55 - 4:20 PM
Andrea Fleig, University of Hawaii, USA
Title: "Natural Products as Modulators of Calcium Signaling in Inflammation"

4:20 - 4:45 PM
Andrew Jenkins, Emory University, USA

Title: "Using Electrophysiology as a Translational Tool in the Ohmic Era"

4:45 - 5:10 PM
Paul Slesinger, Icahn School of Medicine at Mount Sinai, USA
Title: "Targeting GIRK Potassium Channels for Treating Alcoholism"

5:10 - 5:15 PM
Daniel Sauter, Sophion Bioscience, Denmark
Closing Remarks

Back to Overview

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.